Utah Medical Products, Inc. Extends Tender Offer
Shareholders can consider third-quarter financial results scheduled for October 22 before the extended tender deadline.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Utah Medical Products (Nasdaq: UTMD) extended its tender offer expiration to October 27, 2026, giving shareholders more time to decide.
The offer remains for up to 650,000 common shares at $75.00 per share. The new deadline is 5:00 p.m. New York City time, replacing the October 7 deadline. The company said the extension also allows shareholders to consider its calendar third-quarter 2026 financial results, scheduled for October 22. All other offer conditions remain unchanged. Shareholders participating in the offer must deliver the Letter of Transmittal, share certificates and any other required documents to Computershare Trust Company, the depositary.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate point. Forward-looking: it has not happened yet and may not happen.Tender offer provides a capital return through purchases of up to 650,000 common shares at $75.00 per share.
Negative
- Moderate pointTender offer expiration moved from October 7 to October 27, 2026, delaying the deadline.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SALT LAKE CITY, UT / ACCESS Newswire / October 5, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) is offering to purchase up to 650,000 shares of its common stock at
Except for the extended expiration date, all the conditions of the Offer remain the same and are explained in detail by reference in the SEC Form TO-IA Offer to Purchase and Letter of Transmittal filed with the SEC at
https://www.sec.gov/Archives/edgar/data/706698/000109690626001481/0001096906-26-001481-index.htm
The Letter of Transmittal and certificates for Shares and any other required documents should be sent or delivered by each stockholder or his or her broker, dealer, commercial bank, trust company or other nominee to the Depositary at its address set forth below. The Depositary for the Offer is:
| Computershare Trust Company, N.A. | |
| P.O. Box 43011 | |
| Providence, RI 02940-3100 | |
| Attn: Voluntary Corporate Actions |
Additional copies of the Offer to Purchase, the Letter of Transmittal or other tender offer materials may be obtained from the Information Agent and will be furnished at the Company's expense. Questions and requests for assistance concerning the Offer should be directed to the Information Agent:
| Georgeson LLC | |
| 51 West 52nd Street, 6th Floor | |
| New York, NY 10019 | |
| Call Toll Free: (866) 920-7258 |
Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long-term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD's website at www.utahmed.com.
Contact:
Brian Koopman
(801) 566-1200
SOURCE: Utah Medical Products, Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is the new deadline and purchase price for Utah Medical Products' tender offer?
The tender offer expires at 5:00 p.m. New York City time on October 27, 2026, and offers $75.00 per share for up to 650,000 common shares. All conditions other than the expiration date remain unchanged.